Back
LENZ Therapeutics 10K Form
Sell
49
LENZ
LENZ Therapeutics
Last Price:
28.32
Seasonality Move:
-18.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LENZ News And Ratings
See the #1 stock for the next 7 days that we like better than LENZ
LENZ Financial Statistics
Sales & Book Value
| Annual Sales: | $15M |
|---|---|
| Cash Flow: | $-15.93M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.46 |
| Price / Book: | 4.05 |
Profitability
| EPS (TTM): | -5.59730 |
|---|---|
| Net Income (TTM): | $-69.47M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
LENZ Therapeutics Earnings Forecast
Key LENZ Therapeutics Financial Ratios
- Per Share Earnings over the last 3 years have been positive in 0 years.
LENZ Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LENZ |
| Website: | lenz-tx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LENZ Technical Analysis vs Fundamental Analysis
Sell
49
LENZ Therapeutics (LENZ)
is a Sell
Is LENZ Therapeutics a Buy or a Sell?
-
LENZ Therapeutics stock is rated a Sell
The current LENZ Therapeutics [LENZ] share price is $28.43. The Score for LENZ is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.